Pharma sector demands substantial R&D incentives, tax relief & IP framework
04 Jul 2024 //
FINANCIAL EXPRESS
Orchid and Cipla collaborate to launch Cefepime-Enmetazobactam in India
29 Jun 2024 //
INDIANPHARMAPOST
Orchid Pharma receives DCGI approval for Cefepime and Enmetazobactam antibiotic
13 Jun 2024 //
BIOSPECTRUM ASIA
Orchid Pharma gets DCGI approval to manufacture & market antibiotic drug combo
06 Jun 2024 //
PHARMABIZ
UK MHRA approves Advanz Pharma antibiotic for complex infections
05 Apr 2024 //
PHARMACEUTICAL TECHNOLOGY
Xentria & Meitheal Announce Exclusive Licensing Agreement for XTMAB-16
27 Jun 2023 //
BUSINESSWIRE